A Cleveland Clinic study of patients with some features of Cowden syndrome and endometrial cancer shows that certain demographic and clinical features can predict the likelihood of harboring a PTEN or other gene mutation and serve as a catalyst for cancer genetic evaluation.
Precision medicine matches a tumor’s unique genetic information with a targeted therapeutic and can be highly effective — provided the therapy is available. Often it isn’t.
Many patients with glioblastoma or meningioma at Cleveland Clinic are now offered genomic profiling of their tumors. Here’s why, along with a glimpse of where the practice is taking brain tumor therapy.